The Middle East and Africa Migraine Treatment market was valued at USD 65.83 Million in 2022 and is expected to reach USD 128.31 Million by 2030, growing at a CAGR of 8.7% (2023-2030). Get insights on trends, segmentation, and key players with Data B https://www.databridgemarketresearch.com/reports/middle-east-and-africa-migraine-treatment-market